Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
von Beckerath N, Taubert D, Pogatsa-Murray G, Schömig E, Kastrati A, Schömig A. von Beckerath N, et al. Among authors: schomig a, schomig e. Circulation. 2005 Nov 8;112(19):2946-50. doi: 10.1161/CIRCULATIONAHA.105.559088. Epub 2005 Oct 31. Circulation. 2005. PMID: 16260639 Clinical Trial.
Impact of P-glycoprotein on clopidogrel absorption.
Taubert D, von Beckerath N, Grimberg G, Lazar A, Jung N, Goeser T, Kastrati A, Schömig A, Schömig E. Taubert D, et al. Among authors: schomig a, schomig e. Clin Pharmacol Ther. 2006 Nov;80(5):486-501. doi: 10.1016/j.clpt.2006.07.007. Clin Pharmacol Ther. 2006. PMID: 17112805 Clinical Trial.
Are we making efficient use of clopidogrel?
Kastrati A, Schömig A, Schömig E. Kastrati A, et al. Among authors: schomig a, schomig e. Eur Heart J. 2004 Mar;25(6):454-6. doi: 10.1016/j.ehj.2004.02.005. Eur Heart J. 2004. PMID: 15039123 No abstract available.
115 results